Overview

Clinical Trial of Yiqi Wenyang Jiedu Prescription in the Prevention and Treatment of Postoperative Metastasis and Recurrence of Gastric Cancer

Status:
Not yet recruiting

Trial end date:
2024-07-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of Yiqi Wenyang Jiedu prescription for postoperative gastric cancer.

Phase:

Phase 4

Details

Lead Sponsor:

Jie Li